Integration of administrative claims and clinical data to advance real-world evidence generation in oncology
The analysis of NSCLC as a use-case demonstrated that GEx is a valuable data ecosystem with a generalizable working-age patient population and comprehensive data to facilitate timely real-world evidence generation in oncology.
Authors
- Brian Sweet
- Nathan R. Hill (ORCID: https://orcid.org/0000-0001-7927-8678)
- Ruth Wangia Dixon (ORCID: https://orcid.org/0000-0002-0730-2867)
- John Barron (ORCID: https://orcid.org/0000-0001-9447-1572)
- Mark J. Cziraky
- Hanke Zheng (ORCID: https://orcid.org/0000-0002-4992-121X)
- Michael Grabner (ORCID: https://orcid.org/0000-0002-6521-1007)
- Chi Nguyen (ORCID: https://orcid.org/0000-0003-0740-158X)
Institutions
- Bristol-Myers Squibb (Germany) (DE)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/03007995.2025.2482665
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00